Assessing the effectiveness of methotrexate and actinomycin D in the treatment of patients with C-section ectopic pregnancy

Phase 3

• Conditions: C-Section Ectopic Pregnancy.; Ectopic pregnancy, unspecified; O00.9

• Registration Number: IRCT20151020024625N16
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 32

Inclusion Criteria

Confirmed diagnosis of -section ectopic pregnancy

Exclusion Criteria

Gestational age more than 13 weeks at the time of diagnosis
Heavy vaginal bleeding
Hemodynamic changes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
evel of the blood chorionic gonadotropin hormone (BHCG). Timepoint: 4, 7, 14 and 21 days after intervention. Method of measurement: Enzyme-Linked Immunesorbent Assay (ELIZA).